Receptor, Variable region of T cell receptor (TCR) delta chain, Immunoglobulin superfamily domain (IgSF), Cell signaling protein
01
Overview
T cell receptor delta variable 1 (TRDV1) encodes the variable (V) region of the delta chain in γδ T cell receptors, which are less common than conventional αβ T cell receptors but play important roles in mucosal immunity, cancer surveillance, and infection responses. TRDV1 is a member of the immunoglobulin superfamily and contributes to the recognition of non-peptide antigens (such as stress-induced self-antigens MICA/MICB and CD1c) at epithelial surfaces. Engagement of TRDV1-containing γδ TCRs initiates signal transduction via the CD3 complex, leading to T cell activation, cytokine release, and effector responses that are rapid and often "innate-like". Vδ1+ γδ T cells are abundant at epithelial barriers, particularly the gastrointestinal tract, and increase in frequency during certain infections and tumors, reflecting a specialized role in immune surveillance and tissue homeostasis. While no drugs target TRDV1 directly, γδ TCR-based immunotherapies are a promising area of research.
Hypothetical or under investigation: Would include modulation of γδ T cell activation, cytotoxicity, or tissue repair through antigen engagement or receptor blockade/stimulation mechanisms
03
Biological functions
Antigen recognition: Participates in recognition of self and non-self antigens, including non-peptide antigens at epithelial barriersImmune response: Triggers immune responses—bridging innate and adaptive immunity—especially through γδ T cellsTissue surveillance and repair: Involved in tumor immunosurveillance, infection response, and tissue repair, particularly in epitheliaSignal transduction: Mediates signal transduction upon antigen binding, activating downstream pathways such as ITAM phosphorylation, ZAP70 recruitment, and ERK activation to drive T cell expansion and effector differentiation
04
Disease associations
Cancer: Comprises a significant proportion of intraepithelial lymphocytes and tumor-infiltrating lymphocytes, mediating immunosurveillance and anti-tumor activityInfection: Plays roles in the initial immune response to infection, especially at mucosal barriersInflammation/Autoimmunity: Potentially involved via tissue damage sensing and cytokine productionOther: Associated with tissue damage repair and responses to cellular stress
05
Safety considerations
Potential for off-target immune activation: Manipulating γδ T cells or their receptors may result in broad immune effects, including excessive inflammation or tissue damage.Cytokine release syndrome: As seen with other engineered T cell therapies, is a theoretical concern.Limited specificity: Difficulty targeting Vδ1 cells specifically without affecting other immune subpopulations
06
Interacting drugs
None specifically approved or clinically established yet for TRDV1 or TRDV1-expressing cells.
1 more in the full profile.
07
Biomarkers
Increased frequencies of Vδ1+ γδ T cells can serve as a potential biomarker in certain tumors (for intratumoral immune infiltration), epithelial stress, or infectionCD1c and MIC family (MICA/MICB) engagement serves as surrogate markers for Vδ1 TCR activity
Beyond the preview
Go deeper on T cell receptor delta variable 1 (TRDV1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Drug pipeline
Full profile access
Explore the programs pursuing this target and their development progress.
Drug candidates
Developers
Development stage
Clinical trials
Full profile access
Follow the clinical studies evaluating therapies directed at this target.
Trial design
Status
Readouts
Competitive landscape
Full profile access
Compare approaches across drug candidates, modalities, and indications.
Programs
Modalities
Indications
Literature & evidence
Full profile access
Investigate the research and source evidence behind target biology and development.
Publications
Sources
Analysis
Patents
Full profile access
Explore patent activity around therapies and technologies addressing this target.
Patents
Assignees
Technologies
Research & analysis
Full profile access
Connect target biology, drug development, and emerging evidence in your research.
Biology
Development news
Analysis
Bring the full picture into focus.
See how Gosset can support your research on T cell receptor delta variable 1 (TRDV1).